Granulocyte colonoy stimulating factor (G-CSF)

 

Product description

The present Competitive Intelligence Report about G-CSF & GM-CSF products in the pipeline and off-patent products provides a competitor evaluation in the field of G-CSF & GM-CSF branded products, off-patent products, biosimilars (biogenerics, follow-on biologics) and next generation, longer acting products or new uses of G-CSF as of May 2008.

The report includes a compilation of currently marketed branded and off-patent G-CSF and GM-CSF proudcts for treatment of chemotherapy-induced neutropenia. The report includes the market size of branded G-CSF products in 2007. It lists the most advanced biosimilars of G-CSF and pegylated G-CSF and of GM-CSF. It describes the companies with G-CSF and GM-CSF products and of pegylated versions in off-patent countries. Competitor projects are listed in a tabular format providing Information on:

• Drug Codes,
• Target / Mechanism of Action,
• Class of Compound,
• Company,
• Product Category,
• Indication,
• R&D Stage and
• additional comments with a hyperlink leading to the source of information.

Index

• 2007 Market of branded G-CSF products
• Biosimilar G-CSF products
• Next generation G-CSF products and uses
• Off-patent G-CSF products
• Off-patent pegylated G-CSF products
• Branded GM-CSF products
• Off-patent and follow-up GM-CSF products
• About La Merie